Tsetis Group

Tsetis Group, also known as the Tsetis Pharmaceutical Group of Companies (OFET), is a prominent Greek pharmaceutical conglomerate with a robust international footprint. The group consists of several key entities, including Uni-Pharma, InterMed, Pharmabelle, and Tsetis Nanomed, which specialize in the research, development, and manufacturing of pharmaceuticals, medical devices, and nutritional supplements. With three state-of-the-art production facilities in Greece, the group produces a wide range of products exported to over 60 countries. Tsetis Group is a market leader in thyroid treatments and is increasingly focused on advanced drug delivery systems through its nanotechnology division. The company is recognized for its commitment to innovation, sustainability, and corporate social responsibility under the leadership of Julia Tsetis.